Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: Wilfredo Pagani who wrote (574)	3/9/1998 10:51:00 PM
From: SG	Read Replies (1) \| Respond to of 965

Thanks for info; it corrsponds with mine. It is still probably the best hope for those with med resistant Crohn's who have expeerienced other available treatments without relief. SG

To: Wilfredo Pagani who wrote (574)	3/26/1998 12:49:00 AM
From: puborectalis	Read Replies (1) \| Respond to of 965

Avakine..what phase of testing (FDA) is it? Is this drug a one-time IV administration? What is the incidence of neoplasia? What academic centers are investigating this drug?